Germline Mutations in Pancreatic Adenocarcinoma

Clinical trial NCT03982446 · COMPLETED

Trial details

NCT number: NCT03982446
Sponsor: Hellenic Cooperative Oncology Group
Status: COMPLETED
Study type: OBSERVATIONAL

Germline Mutation Abnormality Pancreatic Cancer Predisposition, Genetic Hereditary Cancer

Start date: 2016-03-01
Primary completion: 2019-11-01
Enrollment: 549

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.